Cargando…
COST OF FEBRILE NEUTROPENIA TREATMENT IN BOSNIA AND HERZEGOVINA
Febrile neutropenia is common chemotherapy complication significantly impacting patient’s outcomes, quality of life and costs, too. Febrile neutropenia (FN) often leads to hospitalization, the need for intravenous antibiotics and use of granulocyte colony-stimulating factors (GCSF) in order to avoid...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AVICENA, d.o.o., Sarajevo
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851529/ https://www.ncbi.nlm.nih.gov/pubmed/27147916 http://dx.doi.org/10.5455/msm.2016.28.112-114 |